Oral delivery of glutathione: antioxidant function, barriers and strategies

Abstract

Glutathione (GSH) is a tripeptide with potent antioxidant activity, which is involved in numerous basic biological processes and has been used for interventions in various degenerative diseases. However, oral delivery of GSH remains challenging, similarly to that of other protein and peptide drugs, because the physicochemical barriers in the gastrointestinal (GI) tract lead to low oral bioavailability. Although several approaches have been explored to improve delivery, such as co-administration with penetration enhancers and enzymatic inhibitors, or encapsulation into nanoparticles, microemulsions and liposomes, appropriate formulations with clinical therapeutic effects remain to be developed. This review discusses approaches explored to developing an oral GSH delivery system that could provide protection against proteolytic degradation in the GI tract and enhance molecular absorption across the epithelial membrane. This system may be beneficial for the design and development of an oral formulation of GSH in the future.

Enhanced Cellular Uptake and Transport of Bovine Lactoferrin Using Pectin- and Chitosan-Modified Solid Lipid Nanoparticles

“…Available evidence indicates that LRP1 serves a dual role as both an endocytic receptor and a signaling receptor [ 58 , 59 , 60 , 61 ]. With respect to the particles incorporating FITC-labeled bLf, the cellular uptake and transport appeared to be temperature- and energy-dependent, and the P app increased when the P-gp inhibitor (verapamil) was added, which prompted us to speculate that the cellular uptake of SLPs primarily occurs through endocytosis, with active transportation facilitated by P-glycoprotein (P-gp) also playing a significant role [ 62 , 63 , 64 ].…”

Lipoic acid-mediated oral drug delivery system utilizing changes on cell surface thiol expression for the treatment of diabetes and inflammatory diseases

“…It not only elevated the expression of thiol groups on the cell surface but also promotes the increase of intracellular reducing substances such as glutathione (GSH). 45,46 Studies have shown that GSH, exported from the cytoplasm, could participate in cell surface disulfide covalent exchange reaction. 47 GSH content results showed that Res incubation significantly increased intracellular GSH content in both inflammatory and non-inflammatory macrophages (Fig.…”

Exosome derived from stem cell: A promising therapeutics for wound healing

“…According to different sources, it can be divided into allografts of human origin and xenografts of animal origin ( FerreiraCastropaggiaro et al, 2011 ). This way provides a physical barrier from bacteria ( Wei et al, 2022 ) and trauma and can keep a moist microenvironment in the wound bed ( Dai et al, 2020 ), but allogenic skin grafts have the risk of immune rejection ( Iy and Al-Rubaiy, 2009 ).…”